Eledon Pharmaceuticals (ELDN) Assets Average (2014 - 2026)
Eledon Pharmaceuticals posted quarterly Assets Average of $157.8 million for Q1 2026, down 6.8% year-on-year from $169.4 million in Q1 2025, and up 5.62% on a QoQ basis from $149.4 million in Q4 2025.
Eledon Pharmaceuticals (ELDN) has 13 years of Assets Average data on file, last reported at $157.8 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average fell 6.8% year-over-year to $157.8 million; the trailing twelve-month figure through Mar 2026 stood at $157.8 million (down 6.8% YoY), and the FY2025 full-year result was $173.2 million, up 30.0% from the prior year.
- Assets Average for Q1 2026 stood at $157.8 million, up from $149.4 million in the prior quarter.
- Across five years, Assets Average topped out at $169.4 million in Q1 2025 and bottomed at $84.9 million in Q1 2024.
- The 5-year median for Assets Average is $137.4 million (2025), against an average of $128.8 million.
- The widest annual swing landed in 2023, when Assets Average tumbled 47.25%; it then surged 99.38% in 2025.
- A 5-year view of Assets Average shows it stood at $121.2 million in 2022, then slipped by 23.62% to $92.6 million in 2023, then jumped by 57.71% to $146.0 million in 2024, then rose by 2.36% to $149.4 million in 2025, then rose by 5.62% to $157.8 million in 2026.
- The last three Assets Average figures came in at $157.8 million (Q1 2026), $149.4 million (Q4 2025), and $137.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13.04 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 33.42 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.72 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 331.70 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 40.89 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 26.06 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 26.03 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 40.71 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 5.05 Bn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - | 157.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 157.84 Mn |
| Dec 31, 2025 | 149.43 Mn |
| Sep 30, 2025 | 137.38 Mn |
| Jun 30, 2025 | 153.11 Mn |
| Mar 31, 2025 | 169.36 Mn |
| Dec 31, 2024 | 145.99 Mn |
| Sep 30, 2024 | 117.53 Mn |
| Jun 30, 2024 | 100.65 Mn |
| Mar 31, 2024 | 84.94 Mn |
| Dec 31, 2023 | 92.57 Mn |
| Sep 30, 2023 | 101.43 Mn |
| Jun 30, 2023 | 94.55 Mn |
| Mar 31, 2023 | 87.55 Mn |
| Dec 31, 2022 | 121.19 Mn |
| Sep 30, 2022 | 152.15 Mn |
| Jun 30, 2022 | 158.04 Mn |
| Mar 31, 2022 | 165.96 Mn |
| Dec 31, 2021 | 173.86 Mn |
| Sep 30, 2021 | 180.74 Mn |
| Jun 30, 2021 | 187.99 Mn |
| Mar 31, 2021 | 194.43 Mn |
| Dec 31, 2020 | 194.89 Mn |
| Sep 30, 2020 | 101.54 Mn |
| Jun 30, 2020 | 12.11 Mn |
| Mar 31, 2020 | 12.33 Mn |
| Dec 31, 2019 | 13.07 Mn |
| Sep 30, 2019 | 16.72 Mn |
| Jun 30, 2019 | 15.83 Mn |
| Mar 31, 2019 | 15.24 Mn |
| Dec 31, 2018 | 18.48 Mn |
| Sep 30, 2018 | 21.45 Mn |
| Jun 30, 2018 | 24.44 Mn |
| Mar 31, 2018 | 23.40 Mn |
| Dec 31, 2017 | 21.96 Mn |
| Sep 30, 2017 | 24.93 Mn |
| Jun 30, 2017 | 26.34 Mn |
| Mar 31, 2017 | 13.51 Mn |
| Dec 31, 2016 | 18.96 Mn |
| Sep 30, 2016 | 41.79 Mn |
| Jun 30, 2016 | 52.28 Mn |
| Mar 31, 2016 | 62.84 Mn |
| Dec 31, 2015 | 72.79 Mn |
| Sep 30, 2015 | 82.51 Mn |
| Jun 30, 2015 | 92.03 Mn |
| Mar 31, 2015 | 102.20 Mn |
| Dec 31, 2014 | 107.36 Mn |